Pericarditis resident survival guide

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]

Pericarditis Resident Survival Guide Microchapters
Overview
Causes
Diagnosis
Treatment
Acute Pericarditis
Recurrent Pericarditis
Etiology Specific
Do's
Don'ts

Synonyms and keywords: Myopericarditis, perimyocarditis

Overview

Pericarditis is the inflammation of the fibroelastic sac surrounding the heart (pericardium). Pericarditis is divided into acute (<6 weeks), subacute (6 weeks to 6 months) and chronic (>6 months) and it can be dry, fibrinous or effusive independently of the etiology. Myopericarditis, or perimyocarditis refers to acute pericarditis associated with myocardial inflammation that leads to global or regional myocardial dysfunction and elevation in the concentration of troponins, creatine kinase MB, myoglobin and tumour necrosis factor.[1] Always suspect pericarditis in the presence of pleuritic chest pain and pericardial friction rub. NSAIDs are the mainstay of the treatment of acute pericarditis; ibuprofen is the most preferred drug due to its favorable effect on the coronary flow.[2]

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Diagnosis

Shown below is an algorithm summarizing the diagnostic approach to acute pericarditis in adults.[2][5][4]


Click on boxes to expand/collapse detailed information.


 
 
 
 
 
 
 

Characterize the symptoms

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Obtain a detailed history

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Examine the patient

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Order tests (Urgent)

❑ Laboratory tests
❑ ECG
❑ Chest X-ray
❑ Echocardiography
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have at least two of the following criteria for the diagnosis of acute pericarditis?

❑ Characteristic chest pain
❑ Pericardial friction rub
❑ Suggestive ECG changes
❑ Suggestive echocardiography changes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Does the patient have any sign of myocarditis?
 
 
 
 
 
 
 
 
 
Does the patient have any signs suspicious of acute pericarditis?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
 
 
Yes
 
 
No
 
 
 
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acute pericarditis
 
 
 
Myopericarditis
 
 
 
Consider alternative diagnosis and treat accordingly
 
 
 
Consider cardiac MRI (CMR)[6]
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treat as acute pericarditis or myopericarditis if there is delayed enhancement on CMR
 
 

Characterize the symptoms

Chest pain

❑ Sudden onset
❑ Sharp or dull, aching and pressure like
❑ Pleuritic (exacerbated by inspiration and coughing)
❑ Retrosternal
❑ Located in the trapezius muscle ridge
❑ Radiation to the neck or the arms
❑ Affected by position (improved by sitting up and leaning forward)
❑ No pain (uremia and tuberculosis pericarditis develop slowly)

Symptoms associated with pericardial effusion:
❑ Without a hemodynamically significant pericardial effusion

❑ No specific symptoms

❑ With a hemodynamically significant pericardial effusion

Fatigue
Breathlessness
Orthopnea
Dizziness
Hoarseness (recurrent laryngeal nerve compression)
Hiccups (phrenic nerve compression)
Abdominal pain (mesenteric ischemia)
Nausea (diaphragm irritation)
Loss of consciousness
Cool extremities
Peripheral cyanosis
Peripheral edema

Other etiology associated symptoms:
Fever (suggestive of infectious etiology)
Cough (suggestive of infectious etiology)
Palpitations
Malaise
Joint pains (suggestive of autoimmune etiology)
Odynophagia
Weight loss (suggestive of malignant etiology)

Obtain a detailed history

❑ Infections

Pneumonia
Tuberculosis
HIV
❑ Travel history
❑ Travel to Central or South America (Chagas disease)
❑ Travel to Central Asia or South Africa or South America (Tuberculosis)[7]
❑ Travel to North and Central America, such as Ohio and Mississippi River valleys (Histoplasmosis)
❑ Travel to North America (Blastomycosis)

Medications

5-Fluorouracil
Amiodarone
Anticoagulants
Cyclosporine
Cyclophosphamide
Cytarabine
Daunorubicin
Doxorubicin
Drug-induced lupus erythematosus
Methysergide
Penicillins
Sulfa drugs
Thiazides
Thrombolytic agents

❑ Systemic illness

Collagen vascular disease
Hypothyroidism
Inflammatory bowel disease
Malignancy
Uremia

❑ Others

Cardiac surgery
Radiation exposure
Dressler's syndrome
Postpericardiotomy syndrome
Trauma history

Examine the patient

Vital signs
Pulse

Tachycardia (typical)
Bradycardia (in hypothyroidism and uremia)
Pulsus paradoxus (in cardiac tamponade)

Blood pressure

❑ Normal (typical)
Hypotension (in cardiac tamponade)

Temperature

Fever less than 39°C or 102.2°F
Hypothermic (in elderly and renal failure)

Respiratory rate

Tachypnea (typical)

Cardiovascular system

Auscultation
❑ Heart sounds

❑ Normal (typical)
❑ New S3 heart sound
❑ Distant and muffled (in cardiac tamponade)

Murmur (in concomitant heart disease)
Pericardial friction rub

❑ High pitched, scratchy or squeaky sound
❑ Best heard at the left sternal border
❑ Best heard with the diaphragm of the stethoscope
❑ Varies in intensity overtime and needs repeated examinations
{{#ev:youtube|watch?v=EUCp_3_vwtw|300}}

Palpation
Jugular venous pulse

❑ Elevated (in cardiac tamponade and constrictive pericarditis)
Kussmaul sign (in constrictive pericarditis)

Percussion
❑ Cardiac dullness beyond the apical point of maximal impulse (in pericardial effusion)


Respiratory system

Wheeze or rales
Pleural effusion


Abdomen

❑ Pulsatile hepatomegaly (in constrictive pericarditis)
Ascites

Order tests (urgent)

Order laboratory tests (urgent):

CBC (leucocytosis)
ESR (elevated)
C reactive protein (elevated)
Serum cardiac troponin I and T
Creatine kinase (CK-MB)
Serum myoglobin
Serum tumour necrosis factor
Serum urea and creatinine


Order electrocardiogram (urgent):

Typical findings in pericarditis

ST segment elevation in leads I, II, aVL, aVF, and V3-V6
PR segment depression
Low QRS voltage (in large pericardial effusion and constrictive pericarditis)
ST elevation in leads I, II, V2, V3, V4, V5, and V6 depicting acute pericarditis

Electrical alternans (in cardiac tamponade)


Order imaging (urgent):

Chest X-ray

❑ Clear lung fields (typical)
❑ A flask-shaped, enlarged cardiac silhouette (in pericardial effusion and cardiac tamponade)
❑ Lateral view may reveal
❑ Thickened pericardial line (in pericarditis, pericardial effusion)
❑ Irregular contours of cardiac silhouette (in chronic pericarditis, pericardial fibrosis, post surgery, metastasis)
Pericardial effusion


Echocardiography (diagnostic test of choice)

Typical findings in pericarditis
❑ Presence of moderate and large pericardial effusion
❑ Right atrial collapse
❑ Diastolic collapse of right ventricle and left atrium (specific for cardiac tamponade)
❑ Check for concomitant heart disease or paracardial pathology

Does the patient have at least two of the following criteria for the diagnosis of acute pericarditis?

❑ Characteristic chest pain

❑ Sharp and pleuritic that is improved by sitting up and leaning forward

Pericardial friction rub

❑ High pitched, scratchy sound at the left sternal border best heard with the diaphragm of the stethoscope
❑ Heard during atrial systole, ventricular systole and rapid ventricular filling in early diastole

❑ Suggestive ECG changes

❑ Diffuse ST elevation with reciprocal ST depression in leads aVR and V1

❑ Suggestive echocardiography changes

❑ New or worsening pericardial effusion

Does the patient have any sign of myocarditis?

❑ Elevated cardiac enzymes, or
❑ Global or regional myocardial dysfunction on echocardiography

Does the patient have any signs suspicious of acute pericarditis?

❑ Ongoing fever
❑ Poor response to treatment

❑ Hemodynamic compromise

Treatment

Treatment of Acute Pericarditis

Shown below is an algorithm summarizing the management of acute pericarditis in adults.[2][5][4]

Click on boxes to expand/collapse detailed information.


 
 
 
 
 
 
 
 
 
 
 

Does the patient have high risk features?

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Yes
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inpatient treatment
 
 
 
 
 
 
 
 
 
 
 
 
Outpatient treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stable patient
 
 
 
 
 
Unstable patient
 
 
 
 
 
No previous myocardial infarction
 
 
 
 
Post-MI pericarditis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Initiate medical therapy (first line: NSAIDs)
❑ Oder tests to identify the specific etiology
❑ Order pericardiocentesis if indicated
 
 
 
 
 
❑ Immediately treat cardiac tamponade (Emergency)
❑ Initiate medical therapy (first line: NSAIDs)
❑ Oder tests to identify the specific etiology
 
 
 
 
 
❑ Initiate medical therapy (first line: NSAIDs)
❑ Educate about life style modification
 
 
 
 
❑ Initiate medical therapy (first line: aspirin)
❑ Educate about life style modification
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assess response to treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Response
 
 
 
No response
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Follow up as outpatient
 
 
 
Admit to the hospital
 
 
 
 
 
 
 
 
 

Does the patient have high risk features?

High risk features include:
Fever >38°C
Leucocytosis
❑ Subacute presentation
Cardiac tamponade
❑ Large pericardial effusion
❑ Elevated troponins (myopericarditis)
❑ Concurrent oral anticoagulation
❑ Lack of response to aspirin or NSAIDs after at least 1 wk of therapy
Immunosuppressed state
❑ Acute trauma
❑ Relapsing pericarditis

Management

Initiate medical therapy
Administer NSAIDs (First line)
Avoid NSAIDs in post-MI pericarditis patients
Ibuprofen (first line)

❑ Orally 300-800 mg TDS or QID x 1-2 weeks
❑ Gradual tapering every 2-3 days, OR

Indomethacin

❑ Orally 50 mg TDS x 1-2 weeks
❑ Gradual tapering every 2-3 days for Rx period of 3-4 weeks


OR

Administer Aspirin
❑ Drug of choice in post-MI pericarditis patients
High-dose aspirin:

❑ Orally 800 mg QID or TDS x 7-10 days
❑ Gradual tapering by 800 mg/week for 3 additional weeks

❑ Stop anticoagulants if patient develops pericardial effusion


AND/OR

Administer Colchicine
❑ Combination with NSAIDs (better response rate)[8]
❑ Can be used alone
❑ Orally 0.5 mg BID x 3 months (>70 kg)
❑ Orally 0.5 mg OD x 3 months (≤70 kg)


Administer gastroprotective agents
Misoprostol (600 to 800 mg/day)
OR
Omeprazole (20 mg/day)


Do not administer steroids
❑ Avoid steroids in an initial episode of pericarditis


Order tests to identify the specific etiology
Order specifc tests based on the clinical suspicion
Treat according to the etiology


Order pericardiocentesis in case of
❑ High suspicion of purulent or neoplastic pericarditis
❑ Effusions > 20 mm in echocardiography in diastole
❑ Large or symptomatic effusions despite one week of medical therapy


Management

Treat cardiac tamponade
❑ Immediately transfer the patient to ICU
❑ Perform pericardiocentesis
❑ Monitor telemetry and check vital frequntly
❑ Call cardiology team immediately


Initiate medical therapy
Administer NSAIDs
Avoid NSAIDs in post-MI pericarditis
Ibuprofen (first line)

❑ Orally 300-800 mg TDS or QID x 1-2 weeks
❑ Gradual tapering every 2-3 days,
OR

Indomethacin

❑ Orally 50 mg TDS x 1-2 weeks
❑ Gradual tapering every 2-3 days for Rx period of 3-4 weeks


OR

Administer aspirin
❑ Drug of choice in post-MI pericarditis patients
High-dose aspirin:

❑ Orally 800 mg QID or TDS x 7-10 days
❑ Gradual tapering by 800 mg/week for 3 additional weeks

❑ Stop anticoagulants if patient develops pericardial effusion


AND/OR

Administer colchicine
❑ Combination with NSAIDs (better response rate)[8]
❑ Can be used alone
❑ Orally 0.5 mg BID x 3 months (>70 kg)
❑ Orally 0.5 mg OD x 3 months (≤70 kg)


Administer gastroprotective agents
Misoprostol (600 to 800 mg/day)
OR
Omeprazole (20 mg/day)


Administer steroids
❑ Avoid steroids to treat an initial episode of pericarditis


Order tests to identify the specific etiology
Order specifc tests based on the clinical suspicion
Treat according to the etiology

Management

Initiate medical therapy
Administer NSAID's
Ibuprofen

❑ Preferred
❑ Orally 300-800 mg TDS or QID x 1-2 weeks
❑ Gradual tapering every 2-3 days,
OR

Indomethacin

❑ Orally 50 mg TDS x 1-2 weeks
❑ Gradual tapering every 2-3 days for Rx period of 3-4 weeks


AND/OR

Colchicine
❑ Combination with NSAIDs (better response rate)[8]
❑ Can be used alone
❑ Orally 0.5 mg BID x 3 months (>70 kg)
❑ Orally 0.5 mg OD x 3 months (≤70 kg)

Administer gastroprotective agents

Misoprostol (600 to 800 mg/day)
OR
Omeprazole (20 mg/day)

Avoid steroids
❑ Avoid steroids to treat an initial episode of pericarditis


Educate about life style modification

❑ In case of pericarditis, avoid sternous physical activity until symptom resolution
❑ In case of myopericarditis, avoid competitive sports for six months and until normalization of lab findings


Management

Intitate medical therapy

❑ Administer High-dose aspirin

❑ Orally 800 mg QID or TDS x 7-10 days
❑ Gradual tapering by 800 mg/week for 3 additional weeks

❑ Administer gastroprotective agents

Misoprostol (600 to 800 mg/day)
OR
Omeprazole (20 mg/day)

❑ Stop anticoagulants if patient develops pericardial effusion
❑ Avoid steroids to treat an initial episode of pericarditis


Life style modification
❑ In case of pericarditis, avoid sternous physical activity until symptom resolution
❑ In case of myopericarditis, avoid competitive sports for six months and until normalization of lab findings


Follow up as outpatient

❑ Observe for recurrences or constriction
❑ Assess again at 7 to 10 days for treatment response
❑ At 1 month check blood tests and CRP
❑ Thereafter assess only if symptoms recur

Admit to the hospital

❑ Indication that the underlying cause may not be viral or idiopathic in nature.
❑ Inpatient therapy
Order sepcific tests to identify the etiology and treat accordingly



Treatment of Recurrent Pericarditis

Shown below is an algorithm summarizing the management of recurrent pericarditis in adults which encompass the incessant type (relapses on discontinuation of anti-inflammatory) and the intermittent type (widely varying symptom free interval without medical therapy).[2][5][4]

 
 
 
 
 
 
 
 
 
Recurrent pericarditis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characterize the clinical, EKG and imaging findings

❑ Characteristic acute pericarditis symptoms
❑ Characteristic acute pericarditis EKG changes
❑ Characteristic acute pericarditis echocardiography changes
❑ Massive pericardial effusion, cardiac tamponade, and pericardial constriction are rare
❑ Other clinical suspicion:

❑ Insufficient dose or/and insufficient treatment duration in an autoimmune pericardial disease
Corticosteroid treatment during the first episode
❑ Early corticosteroid treatment causing augmented viral replication
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initiate medical therapy

NSAIDs
❑ Avoid in post-MI pericarditis patients
Ibuprofen:

❑ Preferred
❑ Orally 300-800 mg TDS or QID x 1-2 weeks
❑ Gradual tapering every 2-3 days
OR

Indomethacin:

❑ Orally 50 mg TDS x 1-2 weeks
❑ Gradual tapering every 2-3 days for Rx period of 3-4 weeks


OR

Aspirin
❑ Drug of choice in post-MI pericarditis patients
High-dose aspirin:

❑ Orally 800 mg QID or TDS x 7-10 days
❑ Gradual tapering by 800 mg/week for 3 additional weeks

❑ Stop anticoagulants if patient develops pericardial effusion


AND/OR

Colchicine:
❑ Effective in cases where NSAIDs failed to prevent relapses
❑ Combination with NSAIDs (better response rate)[8]
❑ Can be used alone
❑ Orally 0.5 mg BID x 3 months (>70 kg)
❑ Orally 0.5 mg OD x 3 months (≤70 kg)


Add gastroprotective agents:
Misoprostol (600 to 800 mg/day)
OR
Omeprazole (20 mg/day)


Life style modification


❑ Excercise restriction until symptom resolution

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Multiple relapses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Add corticosteroids

Prednisone: 1-1.5 mg/kg x 1 month

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Positive response
 
No response
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Taper steroids

❑ Taper dose over a three-month period
❑ If symptoms recur

❑ Start the last dose that suppressed the symptoms
❑ Maintain the dose for 2-3 weeks and then taper

❑ Add colchicine or NSAIDs at the end of tapering of steroids

 

❑ Add azathioprine (75–100 mg/day) or cyclophosphamide

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Treatment failure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pericardiectomy

❑ Maintain the patient on steroid free regimen for several weeks before the procedure

Order tests to identify the specific etiology and treat accordingly
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Etiology Specific Management

Clinical subgroups Specific investigations Treatment
Viral pericarditis ❑ Perform testing for viral etiologies in immunocompromised and HIV infected patients not responding to intial management
❑ Diagnostic pericardiocentesis
    ❑ Analysis of pericardial fluid (transudate or exudate)
    ❑ PCR or in-situ hybridisation
CMV pericarditis: Hyperimmunoglobulin OD 4 ml/kg on day 0, 4,and 8; 2 ml/kg on day 12 and 16
Coxsackie B pericarditis: Interferon alpha or beta 2,5 Mio. IU/m2 surface area s.c. 3 x per week
Adenovirus and parvovirus B19 perimyocarditis: Immunoglobulin 10 g IV at day 1 and 3 for 6-8 hours
Purulent pericarditis ❑ Diagnostic pericardiocentesis in cases of high clinical suspicion
    ❑ Gram stain, acid fast stain, fungal stain, and cultures of the pericardial fluid
    ❑ Protein, glucose and cell count of the pericardial fluid
Gram stain, acid fast stain, fungal stain, and cultures of other body fluids
❑ Therapeutic pericardiocentesis or pericardial window
Pericardiectomy may be used in treatment of recurrent pericardial effusion and in patients with dense adhesions, loculated and thick purulent effusion
Antimicrobial therapy in case of bacterial etiology
    ❑ Intiate antistaphylococcal antibiotic plus aminoglycoside, followed by tailored antibiotic therapy according to pericardial fluid and blood cultures
    ❑ Empiric regimen can be started for the following
        ❑ Immunosuppression
        ❑ Concurrent infection at another body site
        ❑ Presence of intravascular lines or prosthetic devices
        ❑ Recent antimicrobial therapy
Antifungal therapy in case of fungal etiology
Tuberculous pericarditis ❑ Diagnostic pericardiocentesis in all suspected tuberculous pericarditis patients
    ❑ PCR of pericardial fluid
    ❑ High adenosine deaminase activity and interferon gamma concentration in pericardial effusion
❑ Pericardial biopsy (rapid diagnosis)
Tuberculin skin test (not helpful)
CT scan and/or MRI of the chest
❑ Culture of sputum, gastric aspirate, and/or urine
❑ Enzyme-linked immunospot (ELISPOT)
❑ Serum titres of antimyolemmal and antimyosin antibodies
Anti-tuberculosis chemotherapy
    ❑ Emperic therapy in TB endemic areas and in cases with high clinical suspicion
Pericardiectomy is warranted in the setting of persistent constrictive pericarditis or when no general improvement after 4-8 weeks following antituberculosis chemotherapy
Prednisone can be used.
Neoplastic pericarditis CT scan and/or MRI of the chest
❑ Diagnostic pericardiocentesis when other tests couldnt identify malignancy
❑ Cytology and tumour markers
❑ Pericardial biopsy
❑ Systemic antineoplastic treatment
❑ Assess the life expectancy of the patients before proceeding with the treatment
    ❑ Better prognosis patients should be treated more aggressively
    ❑ Advanced malignancy should be treated palliatively with pericardiocentesis
❑ Recurrence of pericardial effusion is prevented using any of the following techniques
    ❑ Prolonged pericardiocentesis
    ❑ Pericardial sclerosis
    ❑ Pericardiotomy
    ❑ Intrapericardial chemotherapy
Pericarditis in renal failure ❑ Renal function test
❑ Diagnostic pericardiocentesis
❑ Pericardial biopsy
❑ Uremic pericarditis
    ❑ Hemodialysis or peritoneal dialysis
    ❑ Heparin-free haemodialysis should be used
❑ Dialysis-associated pericarditis
    ❑ Pericardiocentesis for large effusion
    ❑ Pericardiotomy in non resolving effusion
Pericarditis in systemic autoimmune disease ❑ Diagnostic pericardiocentesis
    ❑ Elevated lymphocytes and mononuclear cells > 5000/mm3
    ❑ Antisarcolemmal antibodies
❑ Exclusion of viral and bacterial etiologies
NSAIDs or aspirin or colchicine
❑ Systemic corticosteroid can be used
    ❑ Intrapericardial steroids has less side effects and is highly effective

Do's

Don'ts

References

  1. Imazio M (2012). "Contemporary management of pericardial diseases". Curr Opin Cardiol. 27 (3): 308–17. doi:10.1097/HCO.0b013e3283524fbe. PMID 22450720.
  2. 2.0 2.1 2.2 2.3 Maisch B, Seferović PM, Ristić AD, Erbel R, Rienmüller R, Adler Y; et al. (2004). "Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology". Eur Heart J. 25 (7): 587–610. doi:10.1016/j.ehj.2004.02.002. PMID 15120056.
  3. 3.0 3.1 Imazio M, Spodick DH, Brucato A, Trinchero R, Adler Y (2010). "Controversial issues in the management of pericardial diseases". Circulation. 121 (7): 916–28. doi:10.1161/CIRCULATIONAHA.108.844753. PMID 20177006.
  4. 4.0 4.1 4.2 4.3 Lange RA, Hillis LD (2004). "Clinical practice. Acute pericarditis". N Engl J Med. 351 (21): 2195–202. doi:10.1056/NEJMcp041997. PMID 15548780.
  5. 5.0 5.1 5.2 Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B; et al. (2013). "American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography". J Am Soc Echocardiogr. 26 (9): 965–1012.e15. doi:10.1016/j.echo.2013.06.023. PMID 23998693.
  6. Khandaker MH, Espinosa RE, Nishimura RA; et al. (2010). "Pericardial disease: diagnosis and management". Mayo Clinic Proceedings. Mayo Clinic. 85 (6): 572–93. doi:10.4065/mcp.2010.0046. PMC 2878263. PMID 20511488. Unknown parameter |month= ignored (help)
  7. "WHO launches World health report 2013". Euro Surveill. 18 (33): 20559. 2013. PMID 23968879.
  8. 8.0 8.1 8.2 8.3 Goldfinger S (2014). "A randomized trial of colchicine for acute pericarditis". N Engl J Med. 370 (8): 780. doi:10.1056/NEJMc1315351#SA1. PMID 24552334.
  9. Sternbach, G.; Beck, C. "Claude Beck: cardiac compression triads". J Emerg Med. 6 (5): 417–9. PMID 3066820.
  10. 10.0 10.1 Schiavone WA (2013). "Cardiac tamponade: 12 pearls in diagnosis and management". Cleve Clin J Med. 80 (2): 109–16. doi:10.3949/ccjm.80a.12052. PMID 23376916.


Template:WikiDoc Sources Template:WikiDoc Sources